Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Breast Cancer Research and Treatment|August 28, 2012
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational studyPeter A Kaufman, Adam M Brufsky, Musa Mayer, et al.Journal of Biomedical Optics|January 5, 2011
Image guided near-infrared spectroscopy of breast tissue in vivo using boundary element methodSubhadra Srinivasan, Colin M Carpenter, Hamid R Ghadyani, et al.The Oncologist|February 12, 2020
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine TherapyPeter A Kaufman, Masakazu Toi, Patrick Neven, et al.Biomedical Optics Express|October 3, 2017
Collagen quantification in breast tissue using a 12-wavelength near infrared spectral tomography (NIRST) systemYan Zhao, William R Burger, Mingwei Zhou, et al.Breast Cancer Research and Treatment|August 4, 2007
Cognitive function in breast cancer patients prior to adjuvant treatmentTim A Ahles, Andrew J Saykin, Brenna C McDonald, et al.The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 11, 2018
Goal Attainment and Goal Adjustment of Older Adults During Person-Directed Cancer RehabilitationKathleen Doyle Lyons, Robin M Newman, Peter A Kaufman, et al.Frontiers in Oncology|October 18, 2023
Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancerPeter A Kaufman, Edward Neuberger, Naomi R M Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.Journal of the National Cancer Institute|June 6, 2002
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831Patrick C Roche, Vera J Suman, Robert B Jenkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast CancerXu Cao, Kristen E Muller, Mary D Chamberlin, et al.Pageof 10